Comparison of Myocardial Reperfusion in Patients With Fasting Blood Glucose ≤100, 101 to 125, and >125 mg/dl and ST-Elevation Myocardial Infarction With Percutaneous Coronary Intervention

American Journal of Cardiology

Volumn 102, Issue 11, 2008, Pages 1457-1462

  Fefer, Paul ^a   Hod, Hanoch ^a   Ilany, Jacob ^a   Shechter, Michael ^a   Segev, Amit ^a   Novikov, Ilia ^b   Guetta, Victor ^a   Matetzky, Shlomi ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CREATINE KINASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOGENIC SHOCK; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY STENT; CREATINE KINASE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEART MUSCLE REPERFUSION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD GLUCOSE; FASTING; FEMALE; HEART CONDUCTION SYSTEM; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; STROKE VOLUME; SURVIVAL ANALYSIS; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 56349163955     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.07.031     Document Type: Article

References (26)

1. Mak K.H., Moliterno D.J., Granger C.B., Miller D.P., White H.D., Wilcox R.G., Califf R.M., and Topol E.J. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue plasminogen activator for Occluded coronary arteries. J Am Coll Cardiol 30 (1997) 171-179
2. Capes S.E., Hunt D., Malmberg K., and Gerstein H.C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 (2000) 773-778
3. O'Sullivan J.J., Conroy R.M., Robinson K., Hickey N., and Mulcahy R. In-hospital prognosis of patients with fasting hyperglycemia in patients after first myocardial infarction. Diabetes Care 14 (1991) 758-760
4. Suleiman M., Hammerman H., Boulos M., Kapeliovich M.R., Suleiman A., Agmon Y., Markiewicz W., and Aronson D. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction. A prospective study. Circulation 111 (2005) 754-760
5. Passamani E., and TIMI Study Group. The Thrombolysis In Myocardial Infarction (TIMI) trial. N Engl J Med 312 (1985) 932-936
6. Zeller M., Cottin Y., Brindisi M.C., Dentan G., Laurent Y., Janin-Manificat L., L'Huillier I., Beer J.C., Touzery C., Makki H., Verges B., Wolf J.E., and The RICO Survey Working Group. Impaired fasting glucose and cardiogenic shock in patients with acute myocardial infarction. Eur Heart J 25 (2004) 308-312
7. Ravid M., Berkowicz M., and Sohar E. Hyperglycemia during acute myocardial infarction: a six year follow-up study. JAMA 233 (1975) 807-809
8. Soler N.G., and Frank S. Value of glycosylated hemoglobin measurements after acute myocardial infarction. JAMA 246 (1981) 1690-1693
9. Oswald G.A., Smith C.C., Betteridge D.J., and Yudkin J.S. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J 293 (1986) 917-922
10. Calles-Escandon J., and Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 22 (2001) 787-790
11. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., Yorek M.A., Beebe D., Oates P.J., Hammes H.P., Giardino I., and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000) 787-790
12. Aronson D., Rayfield E.J., and Chesebro J.H. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 126 (1997) 296-306
13. Depre C., Vanoverschelde J.L., and Taegmeyer H. Glucose for the heart. Circulation 99 (1999) 578-588
14. Moreno P.R., Bernardi V.H., Lopez-Cuellar J., Murcia A.M., Palacios I.F., Gold H.K., Mehran R., Sharma S.K., Nemerson Y., Fuster V., and Fallon J.T. Macrophages, smooth muscle cells, and tissue factor in unstable angina: implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation 94 (1996) 3090-3097
15. Moreno P.R., Murcia A.M., Palacios I.F., Leon M.N., Bernardi V.H., Fuster V., and Fallon J.T. Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation 102 (2000) 2180-2184
16. Angiolillo D.J., Fernandez-Ortiz A., Bernardo E., Ramírez C., Sabaté M., Jimenez-Quevedo P., Hernández R., Moreno R., Escaned J., Alfonso F., et al. Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment. Diabetes 54 (2005) 2430-2435
17. Aoki I., Shimoyama K., Aoki N., Homori M., Yanagisawa A., Nakahara K., Kawai Y., Kitamura S.I., and Ishikawa K. Platelet-dependent thrombin generation in patients with diabetes mellitus: effects of glycemic control on coagulability in diabetes. J Am Coll Cardiol 27 (1996) 560-566
18. Oswald G.A., Smith C.C., Delamothe A.P., Betteridge D.J., and Yudkin J.S. Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction. Br Heart J 59 (1988) 663-671
19. Santoro G.M., Valenti R., Buonamici P., Bolognese L., Cerisano G., Moschi G., Trapani M., Antoniucci D., and Fazzini P.F. Relation between ST-segment changes and myocardial perfusion evaluated by myocardial contrast echocardiography in patients with acute myocardial infarction treated by direct angioplasty. Am J Cardiol 82 (1998) 932-937
20. Antoniucci D., Valenti R., Migliorini A., Parodi G., Moschi G., Memisha G., Santoro G.M., and Cerisano G. Impact of insulin-requiring diabetes mellitus on effectiveness of reperfusion and outcome of patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 93 (2004) 1170-1172
21. Iwakura K., Ito H., Ikushima M., Kawano S., Okamura A., Asano K., Kuroda T., Tanaka K., Masuyama T., Hori M., and Fujii K. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 41 (2003) 1-7
22. Grube E., Gerckens U., Yeung A.C., Rowold S., Kirchhof N., Sedgewick J., Yadav J.S., and Stertzer S. Prevention of distal embolization during coronary angioplasty in saphenous vein grafts and native vessels using porous filter protection. Circulation 104 (2001) 2436-2441
23. Topol E.J., and Yadav J.S. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 101 (2000) 570-580
24. Mehta J.L., Nichols W.W., and Mehta P. Neutrophils as potential participants in acute myocardial ischemia: relevance to reperfusion. J Am Coll Cardiol 11 (1988) 1309-1316
25. Díaz R., Goyal A., Mehta S.R., Afzal R., Xavier D., Pais P., Chrolavicius S., Zhu J., Kazmi K., Liu L., et al. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction. JAMA 298 (2007) 2399-2405
26. Aronson D., Rayfield E.J., and Chesebro J.H. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 126 (1997) 296-306